Advertise with us
Medical Group

Journal of Addiction Medicine and Therapeutic Science

ISSN: 2455-3484



Abstract Open Access
Research Article PTZAID: JAMTS-2-111

Fast Treatment of Methamphetamine Related Anxiety and Depressive Disorders: A Novel Approach

Jamshid Ahmadi*

Background: Methamphetamine abuse and dependence is currently a considerable problem.

Objective: To explain the efficacy of buprenorphine in the quick management of methamphetamine related anxiety and depressive disorders and also methamphetamine withdrawal craving.

Results: 52 mg of buprenorphine is very valuable in the treatment of severe methamphetamine related anxiety and depression and also methamphetamine craving.

Discussion: This study lightens that high dose of buprenorphine is quite effective in the lowering of anxiety, depression, and chest pain and methamphetamine withdrawal symptoms. Hence, our finding is a substantial addition to the literature.

Conclusions: We resulted that a single high dose of buprenorphine could quickly subside methamphetamine induced anxiety, depression, psychogenic pain and withdrawal symptoms. It looks that buprenorphine may be a safe and valuable drug for the treatment of the majority of methamphetamine associated disorders.

Published on: Mar 8, 2016 Pages: 1-3

Full Text PDF Full Text HTML DOI: 10.17352/2455-3484.000011